Bausch & Lomb Sunglass Divestiture To Luxottica Will Help Fund Expansion
This article was originally published in The Gray Sheet
Executive Summary
Bausch & Lomb plans to use net proceeds from its $640 mil. cash divestiture of its Rochester, New York-based sunglass operation to Luxottica Group S.p.A. to augment its core portfolio of vision care, pharmaceuticals and ophthalmic surgery products.